Announcements Trials
Browse Landscape

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Tumor-Agnostic 1Other hematologic neoplasm 1Myeloid 1

Conditions

Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Hypertension, Pulmonary 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 447Surgical Procedures, Operative 164Observation 152Drug Therapy 143Radiotherapy 142Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 79Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 67Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 62Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Caves × Clear all
NCT04036045 2025-10-06

Approaches to Identify Early Biomarkers and Pathogenesis of Anthracycline Cardiotoxicity

Connecticut Children's Medical Center

Withdrawn
Tumor-Agnostic

Neoplasms

NCT01805843 2015-09-09

Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia

Medical University of Graz

Completed
16 enrolled
MyeloidOther hematologic neoplasm

Hypertension, Pulmonary, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡